ArticleNeuro-oncology advances

Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy.

Deepak Kumar Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.